Aflac Incorporated (NYSE:AFL) Shares Sold by ING Groep NV

ING Groep NV decreased its holdings in shares of Aflac Incorporated (NYSE:AFLFree Report) by 11.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,596 shares of the financial services provider’s stock after selling 2,807 shares during the period. ING Groep NV’s holdings in Aflac were worth $2,337,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. increased its position in Aflac by 75.2% during the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after purchasing an additional 333,083 shares during the period. Aptus Capital Advisors LLC grew its holdings in shares of Aflac by 79.7% in the 3rd quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock worth $3,058,000 after acquiring an additional 12,131 shares during the period. Transamerica Financial Advisors Inc. acquired a new stake in shares of Aflac in the 3rd quarter worth approximately $979,000. Roxbury Financial LLC acquired a new stake in shares of Aflac in the 4th quarter worth approximately $948,000. Finally, FMR LLC grew its holdings in shares of Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after acquiring an additional 45,745 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity

In related news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AFL. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price target on the stock. Wells Fargo & Company lowered their price target on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday. Truist Financial upped their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Barclays lowered their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Finally, Keefe, Bruyette & Woods lowered their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $102.86.

View Our Latest Research Report on AFL

Aflac Price Performance

Shares of NYSE:AFL opened at $102.04 on Friday. The company has a market cap of $56.69 billion, a P/E ratio of 10.63, a P/E/G ratio of 3.31 and a beta of 0.99. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 52 week low of $78.62 and a 52 week high of $115.50. The business has a fifty day simple moving average of $104.11 and a 200-day simple moving average of $107.35.

Aflac (NYSE:AFLGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be given a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.27%. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s payout ratio is currently 24.17%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Read More

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.